Abstract:Objective: To study the molecular mechanisms responsible for fibrosis in endometriosis by investigating whether the protein expression levels of sphingosine-1-phosphate receptor 3 (S1PR3), one of the five specific receptors of the bioactive sphingolipid sphingosine-1-phosphate (S1P), correlate with fibrosis extent in endometriotic lesions and which are the cellular mechanisms involved in this process. Design: Case-control laboratory study and cultured endometriotic cells. Setting: University research institute and university hospital. Patient(s): A total of 33 women, with and without endometriosis, were included in the study. Interventions(s): Endometriotic lesions were obtained from women with endometriosis (ovarian endometrioma, n = 8; deep infiltrating endometriosis, n = 15; [urological n = 5, gastrointestinal n = 6, and posterior n = 4]) and control endometrium from healthy women, n = 10, by means of laparoscopic and hysteroscopic surgery. The expression of S1PR3 was evaluated using immunohistochemistry and the extent of fibrosis was assessed using Masson's trichrome staining. Human-cultured epithelial endometriotic 12Z cells were used to evaluate the mechanisms involved in the profibrotic effect of S1PR3 activation. Main outcome measure(s): The expression of S1PR3 in endometriotic lesions is positively correlated with endometriosis-associated fibrosis. In addition, S1P induced epithelial-mesenchymal transition (EMT) and fibrosis in epithelial endometriotic cells. Using RNA interference and pharmacological approaches, the profibrotic effect of S1P was shown to rely on S1PR3, thus unveiling the molecular mechanism implicated in the profibrotic action of the bioactive sphingolipid. Result(s): The protein expression levels of S1PR3 were significantly augmented in the glandular sections of endometrioma and deep infiltrating endometriosis of different localizations with respect to the control endometrium and positively correlated with the extent of fibrosis. Sphingosine-1-phosphate was shown to have a crucial role in the onset of fibrosis in epithelial endometriotic cells, stimulating the expression of EMT and fibrotic markers. Genetic approaches have highlighted that S1PR3 mediates the fibrotic effect of S1P. Downstream of S1PR3, ezrin and extracellular-signal-regulated kinases 1 and 2 signaling were found to be critically implicated in the EMT and fibrosis elicited by S1P. Conclusion(s): Sphingosine-1-phosphate receptor 3 may represent a possible innovative pharmacological target for endometriosis.

Blocking Sphingosine 1-Phosphate Receptor 1 with Modulators Reduces Immune Cells Infiltration and Alleviates Endometriosis in Mice.

The Sphingosine 1-Phosphate Axis: an Emerging Therapeutic Opportunity for Endometriosis

Sphingosine-1-phosphate receptor 3 is a non-hormonal target to counteract endometriosis-associated fibrosis

Role of Interleukin-6 and Its Receptor in Endometriosis.

Pigment Epithelium Derived Factor Inhibits the Growth of Human Endometrial Implants in Nude Mice and of Ovarian Endometriotic Stromal Cells in Vitro

Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis

Sphingosine 1‐phosphate signaling axis mediates neuropeptide S‐induced invasive phenotype of endometriotic cells

Exosomes from the Uterine Cavity Mediate Immune Dysregulation via Inhibiting the JNK Signal Pathway in Endometriosis

P-selectin As a Potential Therapeutic Target for Endometriosis.

Inhibition of IGF2BP1 attenuates the progression of endometriosis through PTBP1

Trichostatin A, A Histone Deacetylase Inhibitor, Reduces Lesion Growth and Hyperalgesia in Experimentally Induced Endometriosis in Mice

miR-196b-5p Affects Macrophage Polarization and Inflammation in Endometriosis

Platelets and Regulatory T Cells May Induce a Type 2 Immunity That Is Conducive to the Progression and Fibrogenesis of Endometriosis

Changing Prostaglandin E2 (PGE2) Signaling During Lesional Progression and Exacerbation of Endometriosis by Inhibition of PGE2 Receptor EP2 and EP4

Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression

Progressive Development of Endometriosis and Its Hindrance by Anti-Platelet Treatment in Mice with Induced Endometriosis.

Tranylcypromine, a Lysine-Specific Demethylase 1 (LSD1) Inhibitor, Suppresses Lesion Growth and Improves Generalized Hyperalgesia in Mouse with Induced Endometriosis.

Scutellarin Suppresses Platelet Aggregation and Stalls Lesional Progression in Mouse with Induced Endometriosis

Effect of A-317491 Delivered by Glycolipid-Like Polymer Micelles on Endometriosis Pain

Tetramethylpyrazine Stalls Lesional Progression Via Inducing Senescence in Mouse with Induced Deep Endometriosis

U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-κB Pathway